Early Childhood Diagnosis and Lifelong Management
.1 .1
- Patient: Emma, a 6-year-old girl from Canada.
- Diagnosis: Emma was diagnosed with Beta-Thalassemia Major shortly after her first birthday, following recurrent infections, fatigue, and delayed developmental milestones. Blood tests revealed her hemoglobin levels were significantly low, and genetic testing confirmed her diagnosis.
- Symptoms: From an early age, Emma exhibited signs of chronic fatigue, irritability, and pale skin. Her growth rate was below average, which her pediatrician initially thought might be dietary but was ultimately linked to thalassemia.
- Treatment Plan: Emma undergoes blood transfusions every 3-4 weeks to maintain hemoglobin levels and prevent severe anemia. Iron chelation therapy is also essential, as the frequent transfusions lead to iron overload, which could otherwise harm her liver and heart. Her treatment includes deferasirox, an oral medication for iron chelation.
- Challenges: Emma’s parents have had to adjust to a regular hospital schedule, affecting their work-life balance and creating unique social challenges for Emma as she misses school more often than her peers. Emma has also expressed frustration and sadness over feeling different, which her parents address with counseling support.
- Outcome: Despite the demanding treatment regimen, Emma is thriving with her family’s and school’s support. She attends a support group for children with chronic illnesses, which has helped her feel less isolated. Her teachers provide accommodations to ensure she can keep up academically, and her health team continuously monitors her development.
Reference
- Cappellini, M. D., Cohen, A., Porter, J., Taher, A., & Viprakasit, V. (2020). Guidelines for the management of transfusion-dependent thalassemia (TDT) (4th ed.). Thalassemia International Federation.
Retrieved from https://thalassaemia.org.cy/